Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06960798 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later May 30, 2028 → Oct 30, 2028
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from University of Oklahoma

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 8 more changesShow less
    • Enrollment increased: 150 → 300 participants
    • Start date: Oct 2, 2026 to Nov 2, 2026
    • Trial arms changed: 1 → 2
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoint revised
    • Study description shortened, about 22 words
    • Site contact updated
    • Study title shortened, about 1 word
  2. Start date: May 2, 2026 to Oct 2, 2026
    • Primary completion pushed from May 30, 2028 to Oct 30, 2028
    • Study completion pushed from Jun 30, 2029 to Oct 30, 2029
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prespecified cancers of interest. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Trial Details
NCT Number NCT06960798
Lead Sponsor University of Oklahoma
Conditions
(from sponsor)		 Prostate Cancer, Renal Cell Carcinoma (RCC)
Related terms Carcinoma, Renal Cell, Prostatic Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov